我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

辛伐他汀对原发性高胆固醇血症患者血管内皮功能的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第1期
页码:
62-64
栏目:
临床研究
出版日期:
2007-01-01

文章信息/Info

Title:
Effects of simvastatin on vascular endothelial function in patients with primary hypercholesterolemia
作者:
王立峰1; 王晓云1; 李晓波2; 宁波1; 刘娴1;  徐海龙1
哈尔滨医科大学：1.第四附属医院心内科，2.微生物学教研室，黑龙江 哈尔滨150000
Author(s):
WANG Lifeng1;  WANG Xiaoyun1;  LI Xiaobo2;  NING Bo1;  LIU Xian1;  XU Hailong1
1.Department of Cardiology, Fourth Affiliated Hospital, 2.Department of Microbiology, Harbin Medical University, Harbin 150000,Heilongjiang, China
关键词:
原发性高胆固醇血症; 辛伐他汀; 内皮功能; 内皮素1; 一氧化氮
Keywords:
primary hypercholesterolemia; simvastatin; vascular endothelial function ; endothelin1;  nitric oxide
分类号:
R541.1
DOI:
-
文献标识码:
A
摘要:
目的 探讨辛伐他汀对原发性高胆固醇血症患者血管内皮功能的影响。方法 选择原发性高胆固醇血症患者48例口服辛伐他汀，分别于治疗前、治疗后4周和8周进行血浆内皮素1（ET1）、血清一氧化氮（NO）和血脂等指标测定；另选15例健康体检者为对照。结果 治疗前高胆固醇血症患者组血浆ET1显著高于对照组（P<0.05），而NO显著低于对照组（P<0.0 1）；辛伐他汀治疗4周后，ET1、胆固醇、低密度脂蛋白、三酰甘油均显著降低（P<0.0 1）,NO显著升高（P<0.0 5）,高密度脂蛋白虽亦升高，但无统计学意义；8周后血浆ET1继续降低，血清NO继续升高，但两者与健康对照组比较，无统计学意义。结论 高胆固醇血症患者存在明显的内皮功能损害；辛伐他汀不仅能够显著降低血脂，而且能够改善血管内皮功能。
Abstract:
AIM To investigate the effects of simvastatin on the vascular endothelial function in the patients with primary hypercholesterolemia (HC). METHODS Fortyeight patients with primary hypercholesterolemia were given 20 mg and the plasma endothelin (ET1), serum nitric oxide (NO) and lipidemia were determined before and 4 as well as 8 weeks after treatment. The results were compared with those in 15 healthy subjects (control group). RESULTS ①The plasma ET1 level in the HC group was significantly higher than that in the control group (P<0.05), while the NO level in the HC group was markedly lower than that in the control group (P<0.01). ②4 weeks after treatment, the levels of ET1, TC, TG and LDL in the patients treated with simvastatin significantly decreased (P<0.01) and the levels of NO increased significantly (P<0.01). ③8 weeks after simvastatin treatment, the level of ET1 in the HC group continued to decrease and the level of NO continued to increase. No significant difference was found between the HC group and control group. CONCLUSION Vascular endothelial function is impaired in patients with hypercholesterolemia. Simvastatin not only decreases the levels of lipidemia but also improves the vascular endothelial function.

参考文献/References

［1］Galle J ,Bassenge E ,Busse R. Oxidized low density lipoproteins potentiate vasoconstrictionso various agonists by diret interaciion with vascular smooth muscle［J］. Circ Res,1990,66(5):1287-1293.

［2］刘群锋,马虹,周少春,等. 高脂饮食兔血管内皮功能障碍的早期变化［J］. 心脏杂志,2001,13(5):352-353,356.

［3］吴奇志，翁南星，兰启防，等. 阿托伐他汀钙对原发性高胆固醇血症患者血管皮细胞依赖性舒张功能的影响［J］. 心脏杂志, 2002,14(6):494-496.

［4］Kaesemeyer WH,Caldwell RB,Huang J,et al. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol lowering actions ［J］. J Am Coll Cardiol,1999,33(1):234-241.

［5］Laufs U,La Fata V,Plutzky J,et al. Upregulation of endothelial nitric oxide synthase by HMGCoA reductase inhibitors［J］. Circulation, 1998,97(12):1129-1135.

［6］Kishi T,Hirooka Y,Mukai Y,et al. Atorvastatin causes depressor and sympathoinhibitory effects with upregulation of nitric oxide synthases in strokeprone spontaneously hypertensive rats［J］. J Hypertens,2003,21(2):379-386.

备注/Memo

备注/Memo:
收稿日期：2005-12-13 作者简介：王立峰，硕士生Email：wlf8586@sina.com
更新日期/Last Update: